Authors: Dillman, RO DeLeon, C Beutel, LD Barth, NM Schwartzberg, LS Spitler, LE Garfield, DH O'Connor, AA Nayak, SK

Citation: Ro. Dillman et al., Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma, CR R ONC H, 39(1-2), 2001, pp. 115-123

Authors: Spitler, LE

Citation: Le. Spitler, Adjuvant therapy of melanoma: At what cost?, J CL ONCOL, 19(4), 2001, pp. 1226-1226

Authors: Spitler, LE Grossbard, ML Ernstoff, MS Silver, G Jacobs, M Hayes, FA Soong, SJ

Citation: Le. Spitler et al., Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor, J CL ONCOL, 18(8), 2000, pp. 1614-1621

Authors: Meidenbauer, N Harris, DT Spitler, LE Whiteside, TL

Citation: N. Meidenbauer et al., Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer, PROSTATE, 43(2), 2000, pp. 88-100

Authors: Harris, DT Matyas, GR Gomella, LG Talor, E Winship, MD Spitler, LE Mastrangelo, MJ

Citation: Dt. Harris et al., Immunologic approaches to the treatment of prostate cancer, SEMIN ONCOL, 26(4), 1999, pp. 439-447

Authors: Muderhwa, JM Matyas, GR Spitler, LE Alving, CR

Citation: Jm. Muderhwa et al., Oil-in-water liposomal emulsions: Characterization and potential use in vaccine delivery, J PHARM SCI, 88(12), 1999, pp. 1332-1339